Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation

Cited by (1,005)

Items 801–900 of 1,005

1. Cost Effectiveness of New Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation in Two Different European Healthcare Settings
   Talitha I. Verhoef, Ken Redekop, Fazila Hasrat, Anthonius de Boer, Anke H. Maitland‐van der Zee · 2014 · American Journal of Cardiovascular Drugs
2. Effectiveness and safety of combined antiplatelet and anticoagulant therapy: A critical review of the evidence from randomized controlled trials
   Jeremy S. Paikin, Doug S. Wright, John W. Eikelboom · 2011 · Blood Reviews
3. The Business Case for Quality Improvement
   Adam J. Rose, Dan R. Berlowitz, Arlene S. Ash, Al Ozonoff, Elaine M. Hylek, Jeremy D. Goldhaber‐Fiebert · 2011 · Circulation Cardiovascular Quality and Outcomes
4. Warfarin and atrial fibrillation: from ideal to real the warfarin affaire
   Mauro Molteni, Claudio Cimminiello · 2014 · Thrombosis Journal
5. Beneficial Effect of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation – Results of the J-RHYTHM Registry 2 –
   Eitaro Kodani, Hirotsugu Atarashi, Hiroshi Inoue, Ken Okumura, Takeshi Yamashita, Hideki Origasa, on behalf of the J-RHYTHM Registry Investigators · 2016 · Circulation Journal
6. Comparison of major bleeding risk in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants in the real-world setting: a network meta-analysis
   Steven Bruce Deitelzweig, Caroline Farmer, Xuemei Luo, Xingzheng Li, L. Vo, Jack Mardekian, Kyle R. Fahrbach, Ajibade O. Ashaye · 2017 · Current Medical Research and Opinion
7. Management of atrial fibrillation: two decades of progress — a scientific statement from the European Cardiac Arrhythmia Society
   Samuel Lévy, Gerhard Steinbeck, Luca Santini, Michael Näbauer, Diego Penela, Bharat K. Kantharia, Sanjeev V. Saksena, Riccardo Cappato · 2022 · Journal of Interventional Cardiac Electrophysiology
8. Biomarkers for Atrial Fibrillation Detection After Stroke
   Alan C. Cameron, Huen Ki Cheng, Ren-Ping Lee, Daniel J. Doherty, Mark Hall, Pouria Khashayar, Gregory Y.H. Lip, Terence J. Quinn, Azmil H. Abdul‐Rahim, Jesse Dawson · 2021 · Neurology
9. Transition of Patients From Blinded Study Drug to Open-Label Anticoagulation
   Christian Thomas Ruff, Robert Patrick Giugliano, Eugene Braunwald M. D, Michele F. Mercuri, Valentin Curt, Joshua Betcher, Laura T. Grip, Abby L. Cange, Andrea E. Crompton, Sabina A. Murphy et al. · 2014 · Journal of the American College of Cardiology
10. Apixaban in Patients with Atrial Fibrillation
    Andrew Owen · 2011 · New England Journal of Medicine
11. Valor predictivo de la escala CHA2DS2-VASc en pacientes con fibrilación auricular de alto riesgo embólico en tratamiento anticoagulante
    Eva Jover, Vanessa Roldán, Pilar Gallego, Diana Hernández‐Romero, Mariano Valdés, Vicente Vicente, Gregory Y.H. Lip, Francisco R. Marín · 2012 · Revista Española de Cardiología
12. Warfarin Versus New Agents: Interpreting the Data
    Jack Ansell · 2010 · Hematology
13. Early safety of the Amplatzer Cardiac Plug™ for left atrial appendage occlusion
    David Meerkin, Adi Butnaru, Dmitry Dratva, Olivier Francois Bertrand, Dan Tzivoni · 2013 · International Journal of Cardiology
14. Total Thrombus‐Formation Analysis System (T‐TAS) Can Predict Periprocedural Bleeding Events in Patients Undergoing Catheter Ablation for Atrial Fibrillation
    Miwa Ito, Koichi Kaikita, Daisuke Sueta, Masanobu Ishii, Yu Oimatsu, Yuichiro Arima, Satomi Iwashita, Aya Takahashi, Tadashi Hoshiyama, Hisanori Kanazawa et al. · 2016 · Journal of the American Heart Association
15. Adherence with oral anticoagulation in non-valvular atrial fibrillation: a comparison of vitamin K antagonists and non-vitamin K antagonists
    Rikke Sørensen, Berit Jamie Nielsen, Jannik Langtved Pallisgaard, Christina Ji‐Young Lee, Christian Tobias Torp-Pedersen · 2017 · European Heart Journal - Cardiovascular Pharmacotherapy
16. Patients' experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: A qualitative study
    Danielle E. Clarkesmith, Gregory Y.H. Lip, Deirdre A. Lane · 2017 · Thrombosis Research
17. Predictive performance of the CHA2DS2‐VASc rule in atrial fibrillation: a systematic review and meta‐analysis
    Sander van Doorn, Thomas P. A. Debray, Femke Kaasenbrood, Arno Wilhelmus Hoes, Frans Hendrik Rutten, Karel G.M. Moons, Geert‐Jan Geersing · 2017 · Journal of Thrombosis and Haemostasis
18. Interventional and surgical occlusion of the left atrial appendage
    Etem Caliskan, James L. Cox, David R. Holmes, Bernhard Meier, Dhanunjaya Lakkireddy, Volkmar Falk, Sacha P. Salzberg, Maximilian Y. Emmert · 2017 · Nature Reviews Cardiology
19. Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation
    Abhinav Sharma, Ziad Hijazi, Ulrika Andersson, Sana M. Al‐Khatib, Renato D. Lópes, John Hunter Alexander, Claes Held, Elaine M. Hylek, Sergio Leonardi, Michael Hanna et al. · 2018 · Circulation
20. Utility of left atrial strain for predicting atrial fibrillation following ischemic stroke
    S. Rasmussen, Flemming Javier Olsen, Peter Godsk Jørgensen, Thomas Fritz‐Hansen, Thomas Jespersen, Gunnar Gislason, Tor Biering‐Sørensen · 2019 · International journal of cardiac imaging
21. Cost‐Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5‐Year, Long‐Term Data
    Vivek Yerrapu Reddy, Ronald L. Akehurst, Meghan B. Gavaghan, Stacey L. Amorosi, David R. Holmes · 2019 · Journal of the American Heart Association
22. Safety and efficacy of dronedarone from clinical trials to real-world evidence: implications for its use in atrial fibrillation
    Giuseppe Boriani, Carina Blomström‐Lundqvist, Stefan Hans Hohnloser, Lennart Bergfeldt, Giovanni Luca Botto, Alessandro Capucci, Ignacio Fernández Lozano, Andreas Goette, Carsten Walter Israel, José Luís Merino et al. · 2019 · EP Europace
23. Unanswered questions and research priorities to optimise stroke prevention in atrial fibrillation with the new oral anticoagulants
    Graeme J. Hankey · 2013 · Thrombosis and Haemostasis
24. 2021 Asia Pacific Heart Rhythm Society (APHRS) practice guidance on atrial fibrillation screening
    Ngai‐Yin Chan, Jessica Joan Orchard, Michael‐Joseph F. Agbayani, Dean Boddington, Tze‐Fan Chao, Sofian Johar, Bobby John, Boyoung Joung, Saravanan Krishinan, Rungroj Krittayaphong et al. · 2021 · Journal of Arrhythmia
25. The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non‐valvular atrial fibrillation
    Hendrika Annie van den Ham, Olaf H. Klungel, Hubert G. M. Leufkens, Tjeerd Pieter van Staa · 2012 · Journal of Thrombosis and Haemostasis
26. Atrial Fibrillation and Acute Myocardial Infarction: Antithrombotic Therapy and Outcomes
    Renato D. Lópes, Li Li, Christopher Bull Granger, Tracy Y. Wang, JoAnne Micale Foody, Marjorie Funk, Eric David Peterson, Karen P. Alexander · 2012 · The American Journal of Medicine
27. A Pilot Randomized Controlled Trial of a Decision Support Tool to Improve the Quality of Communication and Decision‐Making in Individuals with Atrial Fibrillation
    Liana Fraenkel, Richard Lewis Street, Virginia R. Towle, John R. O’Leary, Lynne P. Iannone, Peter H. Van Ness, Terri R. Fried · 2012 · Journal of the American Geriatrics Society
28. Risks for stroke and bleeding with warfarin or aspirin treatment in patients with atrial fibrillation at different CHA2DS2VASc scores: experience from the Stockholm region
    Tomas Forslund, Björn Wettermark, Per Erik Wändell, Mia von Euler, Jan Hasselström, Paul Hjemdahl · 2014 · European Journal of Clinical Pharmacology
29. Risk of Stroke or Transient Ischemic Attack After Atrial Fibrillation Ablation with Oral Anticoagulant Use Guided by ECG Monitoring and Pulse Assessment
    Michael P. Riley, Erica S. Zado, Mathew D. Hutchinson, David Lin, Rupa Bala, Fermin Carlos Garcia, David J. Callans, Joshua M. Cooper, Ralph J. Verdino, Sanjay Dixit et al. · 2014 · Journal of Cardiovascular Electrophysiology
30. Association between atrial fibrillation, anticoagulation, risk of cerebrovascular events and multimorbidity in general practice: a registry-based study
    Vigdis Vanbeselaere, Carla Truyers, Steven Elli, Frank Buntinx, Harrie De Witte, Jean‐Marie Degryse, Séverine Henrard, Bert Vaes · 2016 · BMC Cardiovascular Disorders
31. Warfarin Treatment and All‐Cause Mortality in Community‐Dwelling Older Adults with Atrial Fibrillation: A Retrospective Observational Study
    Alberto Pilotto, Pietro Gallina, Massimiliano Copetti, Andrea Pilotto, Francesco Marcato, Anna Maria Mello, Matteo Simonato, Giancarlo Logroscino, Alessandro Padovani, Luigi Ferrucci et al. · 2016 · Journal of the American Geriatrics Society
32. Effects of policy interventions on the introduction of novel oral anticoagulants in Stockholm: an interrupted time series analysis
    Joris J. Komen, Tomas Forslund, Paul Hjemdahl, Morten Tolstrup Andersen, Björn Wettermark · 2016 · British Journal of Clinical Pharmacology
33. Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation
    Inmaculada Hernandez, Yuting Zhang, Maria M. Brooks, Paul K. L. Chin, Samir Saba · 2016 · Stroke
34. Left atrial appendage occlusion using LAmbre Amulet and Watchman in atrial fibrillation
    Shaojie Chen, K. R. Julian Chun, Stefano Bordignon, Felix K. Weise, Takahiko Nagase, Laura Perrotta, Fabrizio Bologna, Boris Schmidt · 2018 · Journal of Cardiology
35. Oral Anticoagulation
    Ertunc Altiok, Nikolaus Marx · 2018 · Deutsches Ärzteblatt international
36. Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation
    Tymon Pol, Ziad Hijazi, Johan Lindbäck, Jonas Oldgren, John Hunter Alexander, Stuart J. Connolly, John W. Eikelboom, Michael D. Ezekowitz, Christopher Bull Granger, Renato D. Lópes et al. · 2021 · Cardiovascular Research
37. Prevention of Cardioembolic Stroke
    William David Freeman, Maria I. Aguilar · 2011 · Neurotherapeutics
38. Chinese guidelines for the diagnosis and management of atrial fibrillation
    Changsheng Ma, Shulin Wu, Shaowen Liu, Yaling Han · 2024 · Pacing and Clinical Electrophysiology
39. Impact of vascular disease in predicting stroke and death in patients with atrial fibrillation: the Danish Diet, Cancer and Health cohort study
    Lars Hvilsted Rasmussen, Torben Bjerregaard Larsen, Karen Margrete Due, Anne Marie Tjønneland, Kim Overvad, Gregory Y.H. Lip · 2011 · Journal of Thrombosis and Haemostasis
40. CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation
    Walid Saliba, Gad Rennert · 2013 · The American Journal of Medicine
41. Atrial Fibrillation in Congestive Heart Failure
    Jens Seiler, William G. Stevenson · 2009 · Cardiology in Review
42. The Emerging Role of Biomarkers in Atrial Fibrillation
    Jelena Kornej, Stavros Z. Apostolakis, Andreas Bollmann, Gregory Y.H. Lip · 2013 · Canadian Journal of Cardiology
43. Coumarins and survival in incident dialysis patients
    Florian Knöll, Gregor Sturm, Claudia Lamina, Emanuel Zitt, F Lins, Otto Freistätter, Florian Kronenberg, Karl Lhotta, U Neyer · 2011 · Nephrology Dialysis Transplantation
44. Added Predictive Ability of the CHA 2 DS 2 VASc Risk Score for Stroke and Death in Patients With Atrial Fibrillation
    Torben Bjerregaard Larsen, Gregory Y.H. Lip, Flemming Skjøth, Karen Margrete Due, Kim Overvad, Lars Hvilsted Rasmussen · 2012 · Circulation Cardiovascular Quality and Outcomes
45. Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial
    Raffaele De Caterina, A. John Camm · 2015 · EP Europace
46. Atrial fibrillation as a complication of ibrutinib therapy: clinical features and challenges of management
    Bronwyn C. Thorp, Xavier Camille Albert Badoux · 2017 · Leukemia & lymphoma/Leukemia and lymphoma
47. Shared Decision-Making as the Future of Emergency Cardiology
    Marc A. Probst, Peter A. Noseworthy, Juan Pablo Brito, Erik P. Hess · 2017 · Canadian Journal of Cardiology
48. Use of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Malignancy: Clinical Practice Experience in a Single Institution and Literature Review
    Anna Rago, Andrea Antonio Papa, Federica Di Meo, Emilio Attena, Paolo Golino, Antonio D’Onofrio, Gerardo Nigro, Vincenzo Russo · 2017 · Seminars in Thrombosis and Hemostasis
49. Primary Nonadherence to Oral Anticoagulants in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort
    Clara Liliana Rodríguez-Bernal, Salvador Peiró, Isabel Hurtado, Aníbal García‐Sempere, Gabriel Sanfélix‐Gimeno · 2018 · Journal of Managed Care & Specialty Pharmacy
50. Role of Thromboelastography and Rotational Thromboelastometry in the Management of Cardiovascular Diseases
    Barbora Korpallová, M. Samoš, T. Bolek, I. Škorňová, F. Kovář, P. Kubisz, J. Staško, M. Mokáň · 2018 · Clinical and applied thrombosis/hemostasis
51. Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study
    Hyunjean Jung, Pil‐Sung Yang, Jung‐Hoon Sung, Eunsun Jang, Hee Joon Yu, Tae‐Hoon Kim, Jae‐Sun Uhm, Jong‐Youn Kim, Hui‐Nam Pak, Moon‐Hyoung Lee et al. · 2019 · Thrombosis and Haemostasis
52. Prevention and treatment of stroke in patients with chronic kidney disease: an overview of evidence and current guidelines
    Dearbhla Kelly, Peter Malcolm Rothwell · 2019 · Kidney International
53. Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in Elderly Asian Patients With Atrial Fibrillation
    Tze‐Fan Chao, Chern‐En Chiang, Jo‐Nan Liao, Tzeng‐Ji Chen, Gregory Y.H. Lip, Shih‐Ann Chen · 2019 · CHEST Journal
54. Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people
    Alison E. Fohner, Renee F. Robinson, Joseph Yracheta, Denise A. Dillard, Brian D. Schilling, Burhan Ahmed Khan, Scarlett E. Hopkins, Bert B. Boyer, Jynene Black, Howard W. Wiener et al. · 2015 · Pharmacogenetics and Genomics
55. Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients
    Steven Bruce Deitelzweig, Allison V. Keshishian, Amiee Luan Kang, Amol D. Dhamane, Xuemei Luo, Neeraja Balachander, Lisa C. Rosenblatt, Jack Mardekian, Jenny Z. Jiang, Hüseyin Yüce et al. · 2021 · Therapeutic Advances in Gastroenterology
56. JCS / JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
    Ono K, Yu‐ki Iwasaki, Masaharu Akao, Takanori Ikeda, Kuniaki Ishii, Yasuya Inden, Kengo Kusano, Yoshinori Kobayashi, Yukihiro Koretsune, Tetsuo Sasano et al. · 2022 · Journal of Arrhythmia
57. Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation
    Saibal Kar, Shephal K. Doshi, Mohamad Adnan Alkhouli, A. John Camm, Megan J. Coylewright, Charles Michael Gibson, Christopher Bull Granger, M. Edip Gurol, Kenneth Huber, MOUSSA C. MANSOUR et al. · 2023 · American Heart Journal
58. Warfarin treatment quality is consistently high in both anticoagulation clinics and primary care setting in Sweden
    Fredrik Björck, Per Sandén, Henrik Renlund, Peter J Svensson, Anders Själander · 2015 · Thrombosis Research
59. New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation
    Yousif Ahmad, Gregory Y.H. Lip, Stavros Z. Apostolakis · 2012 · Expert Review of Cardiovascular Therapy
60. Warfarin use and the risk of mortality, stroke, and bleeding in hemodialysis patients with atrial fibrillation
    Brandon Kai, Yuliya Bogorad, Leigh-Anh Nguyen, Su-Jau Yang, Wansu Chen, Hillard T. Spencer, Albert Yuh‐Jer Shen, Mingsum S Lee · 2017 · Heart Rhythm
61. Anticoagulantes orales directos frente a antagonistas de la vitamina K en pacientes con fibrilación auricular de la práctica clínica: revisión sistemática y metanálisis
    Carlos Escobar, Julio Martí‐Almor, Alejandro Pérez Cabeza, María José Martínez‐Zapata · 2018 · Revista Española de Cardiología
62. CHA2DS2‐VASc score predicts atrial fibrillation recurrence after cardioversion: Systematic review and individual patient pooled meta‐analysis
    Francesco Vitali, Matteo Serenelli, Juhani K.E. Airaksinen, Rita Pavasini, Anna Tomaszuk−Kazberuk, Elżbieta Młodawska, Samuli Jaakkola, Cristina Balla, Lorenzo Falsetti, Nicola Tarquinio et al. · 2018 · Clinical Cardiology
63. Clinical and Economic Implications of AF Related Stroke.
    Ali Ali, Ahmed H. Abdelhafiz · 2016 · PubMed Central
64. A Systematic Review of the Spectrum of Cardiac Arrhythmias in Sub-Saharan Africa
    Matthew Fomonyuy Yuyun, Aimé Bonny, G. André Ng, Karen S Sliwa, André Pascal Kengne, Ashley Chin, Ana Olga Mocumbi, Marcus E. Ngantcha, Olujimi Adeoluwa Ajijola, Gene Bukhman · 2020 · Global Heart
65. GARFIELD-AF: A Worldwide Prospective Registry of Patients With Atrial Fibrillation at Risk of Stroke
    Jean‐Pierre Bassand, Patricia N Apenteng, Dan Atar, A. John Camm, Frank J.S. Cools, Ramon L. Corbalan, David Andrew Fitzmaurice, Keith A.A. Fox, Shinya Goto, Sylvia K. Haas et al. · 2020 · Future Cardiology
66. Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source
    Ashkan Shoamanesh, Robert G. Hart, Stuart J. Connolly, Scott Eric Kasner, Eric Edward Smith, Joan Martí‐Fábregas, Yan‐Yun Liu, Shinichiro Uchiyama, Robert Mikulík, Roland C. Veltkamp et al. · 2020 · JAMA Neurology
67. Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke
    Luis Alberto García Rodríguez, Lucía Cea Soriano, Stine Munk Hald, Jesper Hallas, Yanina Balabanova, Gunnar Brobert, Pareen Vora, Mike Sharma, David Gaist · 2020 · Heart
68. The Interactions of Nintedanib and Oral Anticoagulants—Molecular Mechanisms and Clinical Implications
    Grzegorz Grześk, Anita Woźniak-Wiśniewska, Jan Błażejewski, Bartosz Górny, Łukasz Wołowiec, Daniel Rogowicz, Alicja Nowaczyk · 2020 · International Journal of Molecular Sciences
69. Optimal Duration of Monitoring for Atrial Fibrillation in Cryptogenic Stroke: A Nonsystematic Review
    Essa H. Hariri, Ahmad A. Hachem, Georges Sarkis, Samer Nasr · 2016 · BioMed Research International
70. TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT)
    Smith, Danielle E, Xuereb, Christian Borg, Pattison, Helen M, Lip, Gregory YH, Lane, Deirdre A · 2010 · BMC Cardiovascular Disorders
71. Anticoagulant Prescribing for Non‐Valvular Atrial Fibrillation in the Veterans Health Administration
    Adam J. Rose, Robert Joel Goldberg, David D. McManus, Alok Kapoor, Victoria Wang, Weisong Liu, Hong Yu · 2019 · Journal of the American Heart Association
72. Risks and Benefits of Early Rhythm Control in Patients With Acute Strokes and Atrial Fibrillation: A Multicenter, Prospective, Randomized Study (the RAFAS Trial)
    Junbeom Park, Jaemin Shim, Jung‐Myung Lee, Jin‐Kyu Park, JoonNyung Heo, Yoonkyung Chang, Tae‐Jin Song, Dong‐Hyeok Kim, Hye Ah Lee, Hee Tae Yu et al. · 2022 · Journal of the American Heart Association
73. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population
    Jens Cosedis Nielsen, Yenn‐Jiang Lin, Márcio Jansen de Oliveira Figueiredo, Alireza Sepehri Shamloo, Alberto Alfie, Serge Bovéda, Nikolaos Dagres, Darío Di Toro, Lee L. Eckhardt, Kenneth A. Ellenbogen et al. · 2020 · Heart Rhythm
74. Performance of multilabel machine learning models and risk stratification schemas for predicting stroke and bleeding risk in patients with non-valvular atrial fibrillation
    Juan Lü, R. Hutchens, Joseph Hung, Mohammed Bennamoun, B. McQuillan, Tom G. Briffa, Ferdous Ahmed Sohel, Kevin Murray, Jonathon E Stewart, Benjamin J.W. Chow et al. · 2022 · Computers in Biology and Medicine
75. Pretreatment with rivaroxaban attenuates stroke severity in rats by a dual antithrombotic and anti-inflammatory mechanism
    Peter Kraft, Michael Klaus Schuhmann, Melanie Dittmeier, Felix Fluri, Christoph Kleinschnitz · 2015 · Thrombosis and Haemostasis
76. Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide study
    A. Schjerning Olsen, J. Lindhardsen, G. Gislason, P. McGettigan, M. Hlatky, E. Fosbøl, L. Køber, C. Torp-Pedersen, M. Lamberts · 2015 · British medical journal
77. Stroke prevention: an update
    Marie‐Germaine Bousser · 2012 · Frontiers of Medicine
78. Atrial Fibrillation in the Elderly
    Teerapat Nantsupawat, KENNETH M. NUGENT, Arintaya Phrommintikul · 2013 · Drugs & Aging
79. Quality of individual INR control and the risk of stroke and bleeding events in atrial fibrillation patients: A nested case control analysis of the ACTIVE W study
    Robby Nieuwlaat, Benjamin J. Connolly, Lowiek M. Hubers, Spencer M. Cuddy, John W. Eikelboom, Salim Yusuf, Stuart J. Connolly · 2011 · Thrombosis Research
80. Nrf2 activator ameliorates hemorrhagic transformation in focal cerebral ischemia under warfarin anticoagulation
    Takahiko Imai, Toshinori Takagi, Akira Kitashoji, Keita Yamauchi, Masamitsu Shimazawa, Hideaki Hara · 2016 · Neurobiology of Disease
81. Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden
    Talitha I. Verhoef, Ken Redekop, Sophie Langenskiöld, Farhad Kamali, Mia Wadelius, Girvan Burnside, Anke H. Maitland‐van der Zee, Dyfrig Arwyn Hughes, Munir Pirmohamed · 2016 · The Pharmacogenomics Journal
82. Continued Use of Warfarin in Veterans with Atrial Fibrillation After Dementia Diagnosis
    Ariela R. Orkaby, Al Ozonoff, Joel I. Reisman, Donald R. Miller, Shibei Zhao, Adam J. Rose · 2016 · Journal of the American Geriatrics Society
83. Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non–Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation
    Vivek Yerrapu Reddy, Ronald L. Akehurst, Stacey L. Amorosi, Meghan B. Gavaghan, Deanna S. Hertz, David R. Holmes · 2018 · Stroke
84. A Proposed Strategy for Anticoagulation Therapy in Noncompaction Cardiomyopathy
    Cristina Chimenti, Carlo Lavalle, Michele Magnocavallo, Maria Alfarano, Marco Valerio Mariani, Federico Bernardini, Domenico Giovanni Della Rocca, Gioacchino Galardo, Paolo Severino, Luca Di Lullo et al. · 2021 · ESC Heart Failure
85. Prognosis in Patients with Atrial Fibrillation and CHA2DS2‐VASc Score = 0 in a Community‐Based Cohort Study
    Sophie Taillandier, Jonas Bjerring Olesen, Nicolas Clémenty, I. Lagrenade, Dominique Babuty, Gregory Y.H. Lip, Laurent Fauchier · 2012 · Journal of Cardiovascular Electrophysiology
86. New anticoagulant treatments to protect against stroke in atrial fibrillation
    Tatjana Potpara, Gregory Y.H. Lip, Stavros Z. Apostolakis · 2012 · Heart
87. Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study
    Mariam Anjum, Inger Ariansen, Vidar Hjellvik, Randi Marie Selmer, Lars Jøran Kjerpeseth, Eva Skovlund, Marius Myrstad, Hanne Ellekjær, Ingrid Elisabeth Christophersen, Arnljot Tveit et al. · 2023 · European Heart Journal
88. Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making
    Mark H. Eckman, Ruth E. Wise, Katherine Naylor, Lora Arduser, Gregory Y.H. Lip, Brett M. Kissela M. D, Matthew L. Flaherty, Dawn Kleindorfer, Faisal Khan, Daniel P. Schauer et al. · 2015 · Current Medical Research and Opinion
89. Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion
    Thorsten Lewalter, Prapa Kanagaratnam, Boris Schmidt, Mårten Rosenqvist, Jens Erik Nielsen‐Kudsk, Réda Ibrahim, Bert Albers, A. John Camm · 2014 · EP Europace
90. Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents
    Jean‐Pierre Bassand · 2012 · EP Europace
91. National Utilization Patterns of Warfarin Use in Older Patients with Atrial Fibrillation: A Population-Based Study of Medicare Part D Beneficiaries
    Mukaila A. Raji, Matthew Lowery, Yu‐Li Lin, Yong‐Fang Kuo, Jacques Baillargeon, James S. Goodwin · 2013 · Annals of Pharmacotherapy
92. A Prospective Survey of Atrial Fibrillation Management for Real-world Guideline Adherence: COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF) Registry
    Hyeongsoo Kim, Tae‐Hoon Kim, Myung‐Jin Cha, Jung‐Myung Lee, Junbeom Park, Jin‐Kyu Park, Ki‐Woon Kang, Jaemin Shim, Jae‐Sun Uhm, Jun Kim et al. · 2017 · Korean Circulation Journal
93. Impact of creatinine clearance on outcomes in patients with non-valvular atrial fibrillation: a subanalysis of the J-RHYTHM Registry
    Eitaro Kodani, Hirotsugu Atarashi, Hiroshi Inoue, Ken Okumura, Takeshi Yamashita, Hideki Origasa, J-RHYTHM Registry Investigators · 2017 · European Heart Journal - Quality of Care and Clinical Outcomes
94. Dabigatran, rivaroxaban and apixaban vs. high TTR warfarin in atrial fibrillation
    Sara Själander, Vilhelm Sjögren, Henrik Renlund, Bo G Norrving, Anders Själander · 2018 · Thrombosis Research
95. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Real-life Patients With Atrial Fibrillation. A Systematic Review and Meta-analysis
    Carlos Escobar, Julio Martí‐Almor, Alejandro Pérez Cabeza, María José Martínez‐Zapata · 2018 · Revista Española de Cardiología (English Edition)
96. Stroke type and severity in patients with subclinical atrial fibrillation: An analysis from the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial (ASSERT)
    Kanjana S. Perera, Mukul Sharma, Stuart J. Connolly, Jia Wang, Michael Robert Gold, Stefan Hans Hohnloser, Chu‐Pak Lau, Isabelle C. Van Gelder, Carlos Arturo Morillo, Alessandro Capucci et al. · 2018 · American Heart Journal
97. Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation
    Austin H. Hu, Jingbo Niu, Wolfgang C. Winkelmayer­ · 2018 · Seminars in Nephrology
98. Extended Risk Factors for Stroke Prevention
    Shuai Zhang, Wei Zhang, Guangqian Zhou · 2019 · Journal of the National Medical Association
99. Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation
    Keith A. A. Fox, P. Velentgas, A. Camm, J. Bassand, D. Fitzmaurice, B. Gersh, S. Goldhaber, S. Goto, S. Haas, F. Misselwitz et al. · 2020 · JAMA Network Open
100. Comparative Effectiveness and Safety of Oral Anticoagulants Across Kidney Function in Patients With Atrial Fibrillation
     Xiaoxi Yao, Jonathan Inselman, Joseph S. Ross, Rima Izem, David J. Graham, David Martin, Aliza M. Thompson, Mary Ross Southworth, Konstantinos C. Siontis, Che G. Ngufor et al. · 2020 · Circulation Cardiovascular Quality and Outcomes